Breaking News Instant updates and real-time market news.

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47

Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says

As everyday items get "smart," the technology around artificial intelligence gets more real, Tiernan Ray writes in this week's edition of Barron's, adding that the "rising stars" in this natural evolution of AI include Xilinx (XLNX), Synopsys (SNPS), and Cadence Design (CDNS).Reference Link

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

  • 28

    Sep

XLNX Xilinx
$69.33

0.42 (0.61%)

07/27/17
07/27/17
NO CHANGE
Target $40

Reduce
Xilinx shares remain overvalued, says Nomura Instinet
Nomura Instinet analyst Romit Shah believes Xilinx continues to under-deliver on operating expenses as the quarter and guidance were higher than expected. He believes consensus is preoccupied with unproven markets such as AI and autonomous driving and are ignoring the lack of momentum in the core business. Shah believes Xilinx shares remain overvalued and reiterates his Reduce rating and $50 price target.
07/18/17
LEHM
07/18/17
UPGRADE
Target $60
LEHM
Equal Weight
Xilinx upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Blayne Curtis upgraded Xilinx (XLNX) to Equal Weight saying he sees more downside elsewhere in the U.S. Semiconductors space. The analyst raised his price target for the shares to $60 from $53. The analyst this morning downgraded both AMD (AMD) and Cirrus Logic (CRUS) to Underweight.
07/10/17
JEFF
07/10/17
NO CHANGE
Target $180
JEFF
Buy
Nvidia price target raised to $180 from $140 at Jefferies
Jefferies analyst Mark Lipacis raised his price target for Nvidia (NVDA) shares to $180 from $140 and his three-year bull case earnings per share estimate to $8.00 from $6.50. The chipmaker closed Friday up $3.28 to $146.76. The company's decade long investment in its proprietary GPU-processing language has resulted in a multi-year competitive advantage that has yet to be fully appreciated by investors, Lipacis tells investors in a research note. He sees Nvidia as a key beneficiary as the industry undergoes a "tectonic shift towards a parallel computing model." The analyst keeps a Buy rating on the shares. Lipacis this morning also downgraded Intel (INTC) to Underperform and upgraded both Cavium (CAVM) and Xilinx (XLNX) to Buy.
07/10/17
JEFF
07/10/17
UPGRADE
Target $77
JEFF
Buy
Xilinx upgraded to Buy from Hold at Jefferies
Jefferies analyst Mark Lipacis upgraded Xilinx to Buy and raised his price target for the shares to $77 from $68. Xilinx's recent investment in software tools along with its programmable gate arrays positions it as a beneficiary as the industry undergoes a "tectonic shift towards a parallel computing model," Lipacis tells investors in a research note.
SNPS Synopsys
$80.36

0.3 (0.37%)

12/01/16
NEED
12/01/16
NO CHANGE
Target $66
NEED
Buy
Synopsys price target raised to $66 from $60 at Needham
Needham analyst Richard Valera raised his price target for Synopsys to $66 from $60 after the company delivered "strong" Q4 results. While the company's down year over year backlog despite an increase in duration will likely raise some questions, the analyst is inclined to give Synopsys the benefit of the doubt given its strong recent execution track record. He reiterates a Buy rating on the shares, and says he would a buyer on any post-earnings weakness.
05/18/17
FBCO
05/18/17
NO CHANGE
Target $82
FBCO
Outperform
Synopsys price target raised to $82 from $73 at Credit Suisse
Credit Suisse analyst Farhan Ahmad noted that Synopsys (SNPS) reported better than expected Q2 results and raised FY17 guidance modestly. He views the company as the fastest growing electronic design automation, or EDA, company, adding that he continues to believe it has faster growth than Cadence Design (CDNS) due to its higher exposure to faster growth intellectual property and software businesses. Ahmad raised his price target on Synopsys to $82 from $73 and keeps an Outperform rating on the shares.
05/18/17
NEED
05/18/17
NO CHANGE
Target $77
NEED
Buy
Synopsys light implied Q4 guidance factors in some conservatism, says Needham
Needham analyst Richard Valera said that Synopsys' increased FY17 guidance implies "notably light" Q4 guidance. Management attributed this to lumpiness of hardware, but he also suspects the view includes some conservatism. Valera, who thinks the shares could continue to work higher, raised his price target on Synopsys to $77 from $76 and keeps a Buy rating on the stock.
08/15/17
FBCO
08/15/17
NO CHANGE
Target $90
FBCO
Outperform
Synopsys price target raised to $90 from $82 at Credit Suisse
Credit Suisse analyst Farhan Ahmad raised his price target for Synopsys to $90 from $82 to reflect a more positive view of near-term, and increased confidence in long-term growth. The analyst sees potential upside to Q4 estimates, and reiterates an Outperform rating on the shares.
CDNS Cadence Design
$38.88

0.45 (1.17%)

04/25/17
FBCO
04/25/17
NO CHANGE
Target $31
FBCO
Neutral
Cadence Design price target raised to $31 from $25 at Credit Suisse
Credit Suisse analyst Farhan Ahmad raised his price target for Cadence Design to $31 from $25 after the company beat Street estimate for Q1 EPS but guided Q2 EPS below consensus. The analyst reiterates a Neutral rating on the shares.
04/25/17
DADA
04/25/17
DOWNGRADE
Target $32
DADA
Neutral
Cadence Design downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Thomas Diffely downgraded Cadence Design to Neutral saying the valuation now reflects the company's bullish outlook. The analyst raised his price target for the shares to $32 from $30 following Cadence's Q1 results.
12/12/16
JPMS
12/12/16
DOWNGRADE
Target $25
JPMS
Underweight
Cadence Design downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Sterling Auty downgraded Cadence Design Systems to Underweight saying the shares are at a premium valuation level, which is unsustainable. The analyst keeps a $25 price target for the shares.

TODAY'S FREE FLY STORIES

UNH

UnitedHealth

09:11
10/17/17
10/17
09:11
10/17/17
09:11
Hot Stocks
UnitedHealth sees FY18 adj. EPS in-line with consensus »

Consensus $10.85. Expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SRAX

Social Reality

$2.87

-0.19 (-6.21%)

09:11
10/17/17
10/17
09:11
10/17/17
09:11
Conference/Events
Social Reality to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

HOG

Harley-Davidson

09:11
10/17/17
10/17
09:11
10/17/17
09:11
Hot Stocks
Breaking Hot Stocks news story on Harley-Davidson »

Harley-Davidson says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

09:10
10/17/17
10/17
09:10
10/17/17
09:10
General news
FX Action: The dollar »

FX Action: The dollar…

TDC

Teradata

$32.97

-0.24 (-0.72%)

, GE

General Electric

$23.36

0.38 (1.65%)

09:09
10/17/17
10/17
09:09
10/17/17
09:09
Hot Stocks
GE Aviation and Teradata partner for airline analytics solutions »

GE (GE) Aviation and…

TDC

Teradata

$32.97

-0.24 (-0.72%)

GE

General Electric

$23.36

0.38 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 02

    Nov

V

Visa

$108.30

-0.36 (-0.33%)

09:08
10/17/17
10/17
09:08
10/17/17
09:08
Hot Stocks
Visa and Billtrust partner for B2B virtual card acceptance »

Visa and Billtrust today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 29

    Nov

DGX

Quest Diagnostics

$91.53

0.47 (0.52%)

09:07
10/17/17
10/17
09:07
10/17/17
09:07
Recommendations
Quest Diagnostics analyst commentary  »

Quest Diagnostics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

  • 30

    Nov

HOG

Harley-Davidson

09:07
10/17/17
10/17
09:07
10/17/17
09:07
Recommendations
Harley-Davidson analyst commentary  »

Harley-Davidson Q3 beat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

HOG

Harley-Davidson

$46.57

-0.05 (-0.11%)

09:06
10/17/17
10/17
09:06
10/17/17
09:06
Hot Stocks
Harley-Davidson says Q3 international performance down »

Sees tremendous interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AMDA

Amedica

$0.29

-0.01049 (-3.46%)

09:06
10/17/17
10/17
09:06
10/17/17
09:06
Hot Stocks
Amedica receives positive Nasdaq listing decision »

Amedica announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$13.51

0.31 (2.35%)

09:06
10/17/17
10/17
09:06
10/17/17
09:06
Hot Stocks
MiMedx warns of fake emails »

MiMedx Group warned that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 08

    Nov

  • 09

    Nov

  • 10

    Nov

  • 13

    Nov

  • 14

    Nov

BUD

AB InBev

$125.72

0.36 (0.29%)

09:05
10/17/17
10/17
09:05
10/17/17
09:05
Hot Stocks
Anheuser-Busch, Convoy sign multiyear partnership to advance shipping operations »

Anheuser-Busch and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

09:05
10/17/17
10/17
09:05
10/17/17
09:05
General news
U.S. equities are trading sideways »

U.S. equities are trading…

BKI

Black Knight

$46.85

0.05 (0.11%)

09:04
10/17/17
10/17
09:04
10/17/17
09:04
Hot Stocks
Black Knight, Homebot announce strategic alliance »

Black Knight announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

MS

Morgan Stanley

$48.94

0.64 (1.33%)

09:03
10/17/17
10/17
09:03
10/17/17
09:03
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley »

Morgan Stanley CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

CELG

Celgene

$136.71

0.25 (0.18%)

09:03
10/17/17
10/17
09:03
10/17/17
09:03
Initiation
Celgene initiated  »

Celgene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

ROKU

Roku

$22.19

-0.83 (-3.61%)

09:02
10/17/17
10/17
09:02
10/17/17
09:02
Hot Stocks
Roku expands further into Latin America, to launch two players in region »

Roku, Inc. announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEOT

Neothetics

$0.52

-0.0206 (-3.81%)

09:02
10/17/17
10/17
09:02
10/17/17
09:02
Hot Stocks
Neothetics, Evofem Biosciences announce all-stock merger »

Neothetics (NEOT) and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$22.19

-0.83 (-3.61%)

09:01
10/17/17
10/17
09:01
10/17/17
09:01
Hot Stocks
Roku launches Roku Express in Canada »

Roku, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABEO

Abeona Therapeutics

$16.70

0.6 (3.73%)

09:01
10/17/17
10/17
09:01
10/17/17
09:01
Syndicate
Abeona Therapeutics 5M share Spot Secondary priced at $16.00 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 17

    Oct

NFLX

Netflix

09:00
10/17/17
10/17
09:00
10/17/17
09:00
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

09:00
10/17/17
10/17
09:00
10/17/17
09:00
General news
Fed funds futures are modestly lower, having unwound early gains »

Fed funds futures are…

09:00
10/17/17
10/17
09:00
10/17/17
09:00
General news
Industrial Production to be reported at 09:15 »

September Industrial…

09:00
10/17/17
10/17
09:00
10/17/17
09:00
General news
Industrial Production Capacity Utilization Rate to be reported at 09:15 »

September Industrial…

ACN

Accenture

$139.09

-0.11 (-0.08%)

08:59
10/17/17
10/17
08:59
10/17/17
08:59
Hot Stocks
Accenture enters into exclusive negotiations to acquire Altima »

Accenture has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.